Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • January 17 2024

    Jennifer Calamia, an associate of the Firm, wrote an article for Total Food Service titled: “Online Recruitment of Employees: Navigating the Novel Legal Challenges“.

    Click here to read the article.

  • January 10 2024

    Client Alert: U.S. Department of Labor Announces Final Rule Regarding Classification of Independent Contractors

    Yesterday, the U.S. Department of Labor (“DOL”) unveiled the details of a long-awaited final rule clarifying its guidance on determining whether a worker should be classified as an “employee” or “independent contractor” under the Fair Labor Standards Act (“FLSA”) (the “Final Rule”). The Final Rule takes effect March 11, 2024.

    Click here to read the alert.

  • January 05 2024

    Client Alert: Governor Hochul Proposes Paid Prenatal Leave for New York Employees

    In advance of her upcoming State of the State address, Governor Hochul has announced a first-in-the-nation proposal for paid prenatal leave as part of her legislative agenda for the upcoming year.

    Click here to read the alert.

  • December 28 2023

    Client Alert: UPDATE: New York Minimum Wage Rates Confirmed

    The minimum wage, overtime, tip credit/tip threshold and exempt salary threshold rates for New York employers set forth in our previous Client Alert have now been confirmed and published in the New York State Register. Employers should update their Notice of Pay Rate forms (a/k/a 195.1 forms) to reflect these rates with an effective date of January 1, 2024, and ensure the new forms are put into use starting January 1.

    Click here to read the alert.

  • December 28 2023

    BioCardia, Inc. announced the commencement of its At the Market offering in the amount of $2,750,000. EG&S acted as counsel to the Manager.

  • December 21 2023

    Moleculin Biotech, Inc. (NASDAQ: MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, announced the pricing of its registered direct offering and concurrent private placement.  The gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $4.5 million.  EGS acted as counsel to Maxim Group LLC, the sole placement agent in connection with the offering.

  • December 20 2023

    Mama’s Creations, Inc. announced the closing of its Public Offering in the amount of $9,900,000. EG&S acted as counsel to the Placement Agent.

  • December 20 2023

    TransCode Therapeutics, Inc. announced the closing of its Registered Direct offering of Common Stock in the amount of $1,200,000. EG&S acted as counsel to the Placement Agent.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”